CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

CDMO Subsection

Insights into the latest developments in CDMO services and manufacturing.

Continue reading

Injectables Subsection

Expert perspectives on the evolving needs of injectable therapies and packaging.

Continue reading

Nasal & Pulmonary Subsection

Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability

Continue reading

Advertisement

CPHI Milan
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Advertisement

Solstice

Brown Adipose Tissue as a Therapeutic Model for Obesity Treatment

Obesity is a major concern for governments worldwide. In the UK alone, it is estimated that the direct costs of obesity to the National Health Service total £6 billion ($8.5 billion), with prevalence standing at an astonishing 27% in 2015. In the USA, the rate for adults is higher still, totalling 36.5%. For these reasons, obesity has been labelled ‘a national emergency’ by Jeremy Hunt, the UK’s health secretary and an ‘epidemic crisis’ by the US Surgeon General David Satcher (in 2001). Shahzad Ali from Plasticell navigates the causes and a possible solution to this critical issue.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Tjoapack
Aptar – 08/01/2026